September 11, 2008 - For the fifth year, Siemens Healthcare (www.siemens.com/healthcare) presented the “New Point of View” Preclinical Image of the Year Awards, designed to demonstrate how Siemens preclinical imaging systems help researchers improve the quality of imaging and overall research, at the Siemens Preclinical User’s Group Meeting, held in Nice, France.

The awards are intended to honor pioneering researchers and their contributions. Advanced new imaging solutions and multimodal systems are shedding new light on dissecting disease processes and unlocking potential new treatments. Images were acquired on Siemens preclinical imaging systems: the Inveon preclinical scanner and the microPET (positron emission tomography) and microCAT (computed axial tomography) scanners, which have been long-time industry leaders.

“The ‘New Point of View’ image competition illustrates the breadth and novelty of applications for which preclinical imaging technologies are being used. The potential for breakthrough discoveries will eventually have impact in the clinical environment through translational research,” said Kirti Patel, vice president, Preclinical Solutions, Siemens Healthcare. “Our focus is to provide high-quality preclinical imaging tools and workflow solutions that will speed the discovery process for our customers.”

The “New Point of View” competition was open to anyone with a Siemens preclinical scanner. Researchers were allowed to use any type of radiopharmaceutical tracer or any other contrast material. Entries were judged on scientific merit, the type of information gleaned from the images and the overall quality of the images. All images were judged by a panel of industry experts and members of Siemens Preclinical Research and Development team.

Inveon Image of the Year Winner
“4-Dimensional Dosimetry of 131I-NM404 Using µPET/CT and Pinnacle,” acquired by J. Grudzinski, M. Christensen, W. Tome, M. Bahl and J. Weichert, University of Wisconsin.

Multimodality Image of the Year Winner
“Quantification of PECAM-1 Expression in Regions of Myocardial Infarction Using MR-PET,” acquired by L. Locke, Z. Yang, Y. Zhang, R. Tian, B. Kundu, J. Linden, S. Berr and D. Pan, University of Virginia.

Most Innovative Image of the Year Winner
“Kit-like” labeling of PET tracers: 18F-SiFA for bloodpool imaging of transplanted rat hearts,” acquired by G. Boening, University of Munich.

Drug Discovery Image of the Year Winner
“P-glycoprotein modulation at the rat blood-brain barrier studied with (R)-[11C]-Verapamil PET,” acquired by C. Kuntner, J. Bankstahl, A. Abrahim, R. Karch, J. Stanek, T. Wanek, M. Zsebedics, W. Wadsak, K. Kletter, M. Müller, W. Löscher, O. Langer, Austrian Research Centers GmbH-ARC.

For more information: www.usa.siemens.com/healthcare


Related Content

News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiopharmaceuticals and Tracers

April 5, 2024 — RLS Radiopharmacies, America’s only Joint Commission-accredited radiopharmacy network, today announced ...

Time April 05, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
Feature | PET-CT | By Melinda Taschetta-Millane

According to research conducted by Polaris Market Research, the global positron emission tomography (PET)/computed ...

Time January 17, 2024
arrow
News | Prostate Cancer

January 5, 2024 — Perspective Therapeutics, Inc., announced that it has entered into a patent license agreement with ...

Time January 05, 2024
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
News | RSNA

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
Subscribe Now